2008
DOI: 10.4142/jvs.2008.9.4.387
|View full text |Cite
|
Sign up to set email alerts
|

Implantation of canine umbilical cord blood-derived mesenchymal stem cells mixed with beta-tricalcium phosphate enhances osteogenesis in bone defect model dogs

Abstract: This study was performed to evaluate the osteogenic effect of allogenic canine umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) mixed with beta-tricalcium phosphate (β-TCP) in orthotopic implantation. Seven hundred milligrams of β-TCP mixed with 1 × 106 UCB-MSCs diluted with 0.5 ml of saline (group CM) and mixed with the same volume of saline as control (group C) were implanted into a 1.5 cm diaphyseal defect and wrapped with PLGC membrane in the radius of Beagle dogs. Radiographs of the antebrac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
42
1

Year Published

2010
2010
2019
2019

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 58 publications
(43 citation statements)
references
References 33 publications
0
42
1
Order By: Relevance
“…This increased osteogenesis could be attributable mainly to conversion of mesenchymal stem cells into osteoblasts, as reported by Jiang et al (Jiang et al, 2010). Also, Jang et al (Jang et al, 2008) recorded increased osteogenesis and new bone formation through differentiation of MSCs to osteoblast progenitors when tricalcium phosphate (TCP) was loaded onto canine umbilical cordederived mesenchymal stem cells.…”
Section: Discussionmentioning
confidence: 82%
“…This increased osteogenesis could be attributable mainly to conversion of mesenchymal stem cells into osteoblasts, as reported by Jiang et al (Jiang et al, 2010). Also, Jang et al (Jang et al, 2008) recorded increased osteogenesis and new bone formation through differentiation of MSCs to osteoblast progenitors when tricalcium phosphate (TCP) was loaded onto canine umbilical cordederived mesenchymal stem cells.…”
Section: Discussionmentioning
confidence: 82%
“…For the initial screening of cultured MSCs from the nonhuman species, we used a panel of 43 mAb that contained the following commercially available mAb against human CD3,13,14,19,29,31,34,44,45,49,55,71,73,90,117,146, HLA-ABC, HLA-DR, Sca-1 [45] (Becton Dickinson), CD105 (Ancell Corp.), CD235a (Dako), CD271 (Clone 20.4 against low-affinity nerve growth factor receptor-allophycocyanin; Miltenyi Biotec), ALP (clone B4-78-c; Hybridoma Bank), KDR (R&D Systems), SSEA-4 (clone MC-813-70; Hybridoma Bank), W8B2 against human MSCs antigen-1 (MSCA-1= W8B2-phycoerythrin (PE); Biolegend), W4A5 against MSCs, and neural progenitor cells (W4A5-PE; Biolegend). Additionally, we used a series of mAb that showed reactivity with the CD271 þ subpopulation in human BM with putative MSCs specificity [46].…”
Section: Antibodies Flow Cytometric Analysis and Sortingmentioning
confidence: 99%
“…In orthopedic research, MSCs from goat [6][7][8][9][10][11], dog [12][13][14][15], sheep [16][17][18][19], and pig [20,21] are studied with the aim to correct defects of cartilage and bone. In cardiac research MSCs from dog [22][23][24], pig [25,26], and sheep [27,28] are studied for heart valve reconstruction and for cellular therapy to treat myocardial infarctions.…”
Section: Introductionmentioning
confidence: 99%
“…For example, the construct made of porous cylindrical PLA scaffolds and autologus adipose-derived stem cells have been reported to successfully regenerate skull defects in New Zealand white rabbits (Bella et al, 2008). Similarly, Jang et al have noted the efficiency of construct comprised of beta TCPs and canine umbilical cord blood MSCs in canine cortical defect regeneration (Jang et al, 2008).…”
Section: Scaffold/mscsmentioning
confidence: 99%